Page 113 - Read Online

aneurysm rupture and subarachnoid hemorrhage among inflammation, hemodynamics and vascular remodeling.
compared with those who never used aspirin. [50] These Neurol Res 2006;28:372‑80.
findings were reproduced in a retrospective study of 12. Frösen J, Piippo A, Paetau A, Kangasniemi M, Niemelä M,
Hernesniemi J, Jaaskelainen J. Remodeling of saccular cerebral
747 patients with IAs by Gross et al. [51] subarachnoid artery aneurysm wall is associated with rupture: histological analysis
hemorrhage occurred in 28% of patients with a history of 24 unruptured and 42 ruptured cases. Stroke 2004;35:2287‑93.
of aspirin use versus 40% of patients without a history 13. Rajesh BJ, Sandhyamani S, Bhattacharya RN. Clinico‑pathological
study of cerebral aneurysms. Neurol India 2004;52:82‑6.
of aspirin use. In the previous section, we described 14. Schlote W, Gaus C. Histologic aspects from ruptured and

an imaging protocol (ferumoxytol-enhanced MRI) nonruptured aneurysms. Neurol Res 1994;16:59‑62.
whereby macrophages in IA walls can be visualized. 15. Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF,
In one ferumoxytol-enhanced MRI study, patients Rosenwasser RH, Koch WJ, Dumont AS. Biology of intracranial
were imaged pre- and post-daily aspirin therapy (for aneurysms: role of inflammation. J Cereb Blood Flow Metab
2012;32:1659‑76.
several months). Ferumoxytol signal within the IA walls 16. Turjman AS, Turjman F, Edelman ER. Role of fluid dynamics and
was decreased in these patients postaspirin therapy, inflammation in intracranial aneurysm formation. Circulation
suggesting IA inflammation may have decreased. [52] 2014;129:373‑82.
17. Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical
CONCLUSION studies of atherosclerotic lesions of cerebral berry aneurysms.
J Neuropathol Exp Neurol 1994;53:399‑406.
18. Tamura T, Jamous MA, Kitazato KT, Yagi K, Tada Y, Uno M,
Inflammation has emerged as a probable key mediator of Nagahiro S. Endothelial damage due to impaired nitric oxide
both aneurysmogenesis and aneurysmal destabilization bioavailability triggers cerebral aneurysm formation in female rats.
and rupture. The inflammatory cascade is likely J Hypertens 2009;27:1284‑92.
interrelated with mechanical flow-induced vascular 19. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia‑Cardeña
G. Endothelial dysfunction, hemodynamic forces, and atherogenesis.
dysfunction. Further studies will, hopefully, further Ann N Y Acad Sci 2000;902:230‑9.
define these pathways, aid in our prediction of the 20. Wang Z, Kolega J, Hoi Y, Gao L, Swartz DD, Levy EI, Mocco J,
natural history of an IA in a patient-specific manner, Meng H. Molecular alterations associated with aneurysmal
and identify novel pharmacologic targets to prevent remodeling are localized in the high hemodynamic stress region of
a created carotid bifurcation. Neurosurgery 2009;65:169‑77.
aneurysm growth and rupture. 21. Kilic T, Sohrabifar M, Kurtkaya O, Yildirim O, Elmaci I, Günel M,
Pamir MN. Expression of structural proteins and angiogenic factors
REFERENCES in normal arterial and unruptured and ruptured aneurysm walls.
Neurosurgery 2005;57:997‑1007.
1. Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC Jr, 22. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N.
Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C. Impact of monocyte chemoattractant protein‑1 deficiency on
Recommendations for the management of patients with unruptured cerebral aneurysm formation. Stroke 2009;40:942‑51.
intracranial aneurysms: a Statement for healthcare professionals 23. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and
from the Stroke Council of the American Heart Association. Stroke intracranial aneurysms. Neurosurgery 1999;45:1137‑46.
2000;31:2742‑50. 24. Crompton MR. Mechanism of growth and rupture in cerebral berry
2. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk aneurysms. Br Med J 1966;1:1138‑42.
of rupture of intracranial aneurysms: a systematic review. Stroke 25. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R.
1998;29:251‑6. Structural fragility and inflammatory response of ruptured cerebral
3. Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, aneurysms. A comparative study between ruptured and unruptured
Piepgras DG, Forbes GS, Thielen K, Nichols D, O’Fallon WM, cerebral aneurysms. Stroke 1999;30:1396‑401.
Peacock J, Jaeger L, Kassell NF, Kongable‑Beckman GL, 26. Frösen J, Piippo A, Paetau A, Kangasniemi M, Niemelä M,
Torner JC; International Study of Unruptured Intracranial Aneurysms Hernesniemi J, Jaaskelainen J. Growth factor receptor expression
Investigators. Unruptured intracranial aneurysms: natural history, and remodeling of saccular cerebral artery aneurysm walls:
clinical outcome, and risks of surgical and endovascular treatment. implications for biological therapy preventing rupture. Neurosurgery
Lancet 2003;362:103‑10. 2006;58:534‑41.
4. Heiskanen O, Vilkki J. Intracranial arterial aneurysms in children 27. Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Aziz HA, Shono M,
and adolescents. Acta Neurochir (Wien) 1981;59:55‑63. Satoh K. Endothelial injury and inflammatory response induced by
5. Stehbens WE. Etiology of intracranial berry aneurysms. J Neurosurg hemodynamic changes preceding intracranial aneurysm formation:
1989;70:823‑31. experimental study in rats. J Neurosurg 2007;107:405‑11.
6. Wilkinson IM. The vertebral artery. Extracranial and intracranial 28. Boyle JJ. Macrophage activation in atherosclerosis: pathogenesis
structure. Arch Neurol 1972;27:392‑6. and pharmacology of plaque rupture. Curr Vasc Pharmacol
7. Finlay HM, Whittaker P, Canham PB. Collagen organization in the 2005;3:63‑8.
branching region of human brain arteries. Stroke 1998;29:1595‑601. 29. Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van
8. Meng H, Metaxa E, Gao L, Liaw N, Natarajan SK, Swartz DD, Rooijen N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T.
Siddiqui AH, Kolega J, Mocco J. Progressive aneurysm development Critical roles of macrophages in the formation of intracranial
following hemodynamic insult. J Neurosurg 2011;114:1095‑103. aneurysm. Stroke 2011;42:173‑8.
9. Aoki T, Nishimura M. The development and the use of experimental 30. Caird J, Napoli C, Taggart C, Farrell M, Bouchier‑Hayes D.
animal models to study the underlying mechanisms of CA formation. Matrix metalloproteinases 2 and 9 in human atherosclerotic
J Biomed Biotechnol 2011;2011:535921. and non‑atherosclerotic cerebral aneurysms. Eur J Neurol
10. Tulamo R, Frösen J, Hernesniemi J, Niemelä M. Inflammatory 2006;13:1098‑105.
changes in the aneurysm wall: a review. J Neurointerv Surg 31. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N.
2010;2:120‑30. Macrophage‑derived matrix metalloproteinase‑2 and ‑9 promote
11. Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links the progression of cerebral aneurysms in rats. Stroke 2007;38:162‑9.

Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015 105